Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 22;26(17):8175.
doi: 10.3390/ijms26178175.

Early Diagnosis and Follow-Up of a Novel Homozygous Mutation in SOST Gene in a Child with Recurrent Facial Palsy: A Case Report and Review of the Literature

Affiliations
Review

Early Diagnosis and Follow-Up of a Novel Homozygous Mutation in SOST Gene in a Child with Recurrent Facial Palsy: A Case Report and Review of the Literature

Fabio Acquaviva et al. Int J Mol Sci. .

Abstract

Recurrent facial palsy is a rare event in the pediatric population, mostly idiopathic or associated with common comorbidities or, rarely, observed in syndromic conditions. However, some cases are difficult to explain and need more accurate diagnostic approaches. In this work, we describe a pediatric case of recurrent facial palsy secondary to hyperostosis of the skull and narrowing of the neural foramina related to a SOST-related sclerosing bone dysplasia. To our knowledge, this is the first Italian case that is also related to a novel loss-of-function variant in the SOST gene. We highlight the clinical relevance of a proper early diagnosis and the need for correct monitoring of the clinical evolution, considering the natural history of the disease, to prevent/reduce severe neurological complications.

Keywords: SOST; SOST-related sclerosing bone dysplasia; recurrent facial palsy.

PubMed Disclaimer

Conflict of interest statement

Authors Eloisa Evangelista and Luigia De Falco were employed by the company AMES, Centro Polidiagnostico Strumentale, srl. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Proband at 3 (upper panel) and 4 years (lower panel). See also Supplementary Table S1.
Figure 2
Figure 2
(A). Three-generation pedigree. Filled black symbols indicate the individuals affected with Sclerosteosis, and the shapes partially filled indicate the carriers with heterozygous mutation. The proband is marked with the arrow. (B). Schematic representation of Sclerosteosis-relevant mutations reported ClinVar pathogenic mutations in SOST gene (see also Supplementary Table S2). The new mutations are boxed in the rectangle. (C). Sanger sequencing results of SOST gene variant c.71delA (p.Gln24ArgfsTer33) in the proband (homozygous) and her heterozygous parents. The arrow indicates the position of mutation. (D). SOST model (AF-Q9BQB4-F1-model_v4, SWISS Model Repository) and focus on Gln24 substitution, in bold.
Figure 3
Figure 3
(A). Brain CT (a,b) and MRI (c,d) show sclerosis and hyperostosis with thickening of the cranial theca and basicranium. Arrows indicate the reduction in the caliber of optic foramina and internal acoustic canals (e,f). Spine MRI (g,h) reveals diffuse and mild sclerosis of vertebra both in T1W and T2W. (B). X-ray bone survey shows generalized increase in bone density with diffuse cortical thickening, showed in different sections (a,b,c,d). (C) Five-year follow-up coronal MRI with 3D-DRIVE sequences shows severe stenosis of internal acoustic canals (b) compared to baseline MRI (a). (D). Five-year follow-up CT (a,b) compared to baseline study (c,d) demonstrates progressive increase of hyperostosis and thickening of the cranial theca and temporal bones with severe stenosis of internal acoustic canals (arrows).

References

    1. Sebastian A., Loots G.G. Transcriptional Control of Sost in Bone. Bone. 2017;96:76–84. doi: 10.1016/j.bone.2016.10.009. - DOI - PubMed
    1. Sharifi M., Ereifej L., Lewiecki E.M. Sclerostin and Skeletal Health. Rev. Endocr. Metab. Disord. 2015;16:149–156. doi: 10.1007/s11154-015-9311-6. - DOI - PubMed
    1. He W., Chen C., Pan C., Zhang M., Yu X., Wang D., Hu S. Sclerosteosis Caused by a Novel Nonsense Mutation of SOST in a Consanguineous Family. Clin. Genet. 2016;89:205–209. doi: 10.1111/cge.12655. - DOI - PubMed
    1. Appelman-Dijkstra N., Van Lierop A., Papapoulos S. SOST-Related Sclerosing Bone Dysplasias. In: Adam M.P., Feldman J., Mirzaa G.M., Pagon R.A., Wallace S.E., Amemiya A., editors. GeneReviews®. University of Washington; Seattle, WA, USA: 1993. - PubMed
    1. Balemans W. Increased Bone Density in Sclerosteosis Is Due to the Deficiency of a Novel Secreted Protein (SOST) Hum. Mol. Genet. 2001;10:537–543. doi: 10.1093/hmg/10.5.537. - DOI - PubMed

Substances

LinkOut - more resources